Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 1
1987 1
1992 1
1994 1
1995 1
1999 2
2001 1
2002 5
2003 3
2004 10
2005 9
2006 20
2007 9
2008 15
2009 12
2010 21
2011 18
2012 35
2013 31
2014 42
2015 36
2016 40
2017 41
2018 39
2019 37
2020 51
2021 72
2022 79
2023 65
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

633 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20DW, 5BAuthor
Page 1
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122(11):1764. doi: 10.1002/jcb.30129. Epub 2021 Aug 12. J Cell Biochem. 2021. PMID: 34383349
Retraction: "Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis", by Quanfang Huang, Jinbin Wei, Ling Wei, Xiaolin Zhang, Facheng Bai, Shujuan Wen, Yuanyuan Wei, Shimei Tan, Zhongpeng Lu, and Xing Lin, J Cell Biochem. 2019; 6168-6177: The a …
Retraction: "Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis", by Quanfang Huang, Jinbin Wei, Ling Wei, …
Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Fizazi K, Herrmann K, Krause BJ, Rahbar K, Chi KN, Morris MJ, Sartor O, Tagawa ST, Kendi AT, Vogelzang N, Calais J, Nagarajah J, Wei XX, Koshkin VS, Beauregard JM, Chang B, Ghouse R, DeSilvio M, Messmann RA, de Bono J. Fizazi K, et al. Lancet Oncol. 2023 Jun;24(6):597-610. doi: 10.1016/S1470-2045(23)00158-4. Lancet Oncol. 2023. PMID: 37269841 Clinical Trial.
Patients were randomly assigned (2:1) to receive either [(177)Lu]Lu-PSMA-617 plus protocol-permitted standard of care ([(177)Lu]Lu-PSMA-617 group) or standard of care alone (control group) using permuted blocks. ...Time to worsening was delayed in the …
Patients were randomly assigned (2:1) to receive either [(177)Lu]Lu-PSMA-617 plus protocol-permitted standard of care ([(177) …
Epilepsy in Pregnancy.
Harden C, Lu C. Harden C, et al. Neurol Clin. 2019 Feb;37(1):53-62. doi: 10.1016/j.ncl.2018.09.008. Neurol Clin. 2019. PMID: 30470275 Review.
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
Rugo HS, Diéras V, Gelmon KA, Finn RS, Slamon DJ, Martin M, Neven P, Shparyk Y, Mori A, Lu DR, Bhattacharyya H, Bartlett CHUANG, Iyer S, Johnston S, Ettl J, Harbeck N. Rugo HS, et al. Ann Oncol. 2018 Apr 1;29(4):888-894. doi: 10.1093/annonc/mdy012. Ann Oncol. 2018. PMID: 29360932 Free PMC article. Clinical Trial.
Patient-reported outcomes were assessed at baseline, day 1 of cycles 2 and 3, and day 1 of every other cycle from cycle 5 using the Functional Assessment of Cancer Therapy (FACT)-Breast and EuroQOL 5 dimensions (EQ-5D) questionnaires. RESULTS: As of 26 February 2016, the m …
Patient-reported outcomes were assessed at baseline, day 1 of cycles 2 and 3, and day 1 of every other cycle from cycle 5 using the Function …
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.
Reck M, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Cheng Y, Sakai H, Paz-Ares L, Lu S, John T, Sun X, Moisei A, Taylor F, Lawrance R, Zhang X, Sylvester J, Yuan Y, Blum SI, Penrod JR, Carbone DP. Reck M, et al. Eur J Cancer. 2023 Apr;183:174-187. doi: 10.1016/j.ejca.2023.01.015. Epub 2023 Jan 28. Eur J Cancer. 2023. PMID: 36871487 Free article.
METHODS: In patients (N = 719) randomised 1:1 to nivolumab plus ipilimumab with chemotherapy or chemotherapy alone, disease-related symptom burden and health-related quality of life were assessed using the Lung Cancer Symptom Scale (LCSS) and 3-level EQ-5D (EQ-5D-3L …
METHODS: In patients (N = 719) randomised 1:1 to nivolumab plus ipilimumab with chemotherapy or chemotherapy alone, disease-related symptom …
Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with delirium.
Mortensen CB, Andersen-Ranberg NC, Poulsen LM, Granholm A, Rasmussen BS, Kjær MN, Lange T, Ebdrup BH, Collet MO, Andreasen AS, Bestle MH, Uslu B, Pedersen HS, Nielsen LG, Hästbacka J, Jensen TB, Damgaard K, Sommer T, Morgen M, Dey N, Citerio G, Estrup S, Egerod I, Samuelson K, Perner A, Mathiesen O. Mortensen CB, et al. Intensive Care Med. 2024 Jan;50(1):103-113. doi: 10.1007/s00134-023-07282-7. Epub 2024 Jan 3. Intensive Care Med. 2024. PMID: 38170227 Free PMC article. Clinical Trial.
METHODS: We conducted pre-planned analyses of 1-year outcomes in the Agents Intervening against Delirium in the ICU (AID-ICU) trial, including mortality and health-related quality of life (HRQoL) assessed by Euroqol (EQ) 5-dimension 5-level questionnaire (EQ-5D-5L) index v …
METHODS: We conducted pre-planned analyses of 1-year outcomes in the Agents Intervening against Delirium in the ICU (AID-ICU) trial, includi …
Untethered Microrobots for Active Drug Delivery: From Rational Design to Clinical Settings.
Liu D, Wang T, Lu Y. Liu D, et al. Adv Healthc Mater. 2022 Feb;11(3):e2102253. doi: 10.1002/adhm.202102253. Epub 2021 Dec 1. Adv Healthc Mater. 2022. PMID: 34767306 Review.
In this review, the therapeutic benefits of active DDS are presented compared to the traditional passive DDS, which illustrate the historical reasons for choosing active DDS. An integrated 5D radar chart analysis model containing the core capabilities of the active DDS is …
In this review, the therapeutic benefits of active DDS are presented compared to the traditional passive DDS, which illustrate the historica …
Posterior malleolus fracture: a mid-term follow-up.
Quan Y, Lu H, Qi P, Tian S, Liu J, Zhang C, Zhang B, Xu H. Quan Y, et al. J Orthop Surg Res. 2023 Jan 4;18(1):10. doi: 10.1186/s13018-022-03488-5. J Orthop Surg Res. 2023. PMID: 36600304 Free PMC article.
The Olerud-Molander Ankle Score (OMAS), EuroQol-5 Dimensions (EQ-5D) and American Orthopedic Foot and Ankle Society (AOFAS) score were recorded. ...Among the patients with small fragments, the surgical fixation group also had higher OMAS (93.1 7.5 vs. 83.5 19.5, P = 0.042) …
The Olerud-Molander Ankle Score (OMAS), EuroQol-5 Dimensions (EQ-5D) and American Orthopedic Foot and Ankle Society (AOFAS) score wer …
The efficacy and safety of first-line single-agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-analysis.
Li J, Li S, Yu H, Wang J, Xu C, Lu X. Li J, et al. Gynecol Oncol. 2018 Feb;148(2):247-253. doi: 10.1016/j.ygyno.2017.11.031. Epub 2017 Dec 6. Gynecol Oncol. 2018. PMID: 29203174 Review.
Treatments were grouped into weekly intramuscular MTX(w-IM MTX), five-day intramuscular MTX(5d-IM MTX), five-day intravenous MTX(5d-IV MTX), eight-day intramuscular MTX with folinic acid(MTX-FA), five-day intravenous Act-D(5d-IV Act-D), and bi-weekly pulsed i …
Treatments were grouped into weekly intramuscular MTX(w-IM MTX), five-day intramuscular MTX(5d-IM MTX), five-day intravenous MTX(5 …
Patients' Perspective in Hereditary Ataxia.
Gorcenco S, Karremo C, Puschmann A. Gorcenco S, et al. Cerebellum. 2024 Feb;23(1):82-91. doi: 10.1007/s12311-022-01505-1. Epub 2022 Dec 16. Cerebellum. 2024. PMID: 36525215 Free PMC article.
We designed a questionnaire with 32 multiple-choice or open-ended questions on disability and impairment of daily life activities, the perceived effect of symptomatic and supportive therapies, coping strategies, and how they used and experienced various sources of information abo …
We designed a questionnaire with 32 multiple-choice or open-ended questions on disability and impairment of daily life activities, the perce …
633 results